Article

Cushing's Syndrome Pharma Focus: Cortisol-Inhibiting Medications

Information about four different types of medications are provided here, cortisol-inhibiting medications that may be used for the treatment of Cushing's Syndrome.

Please click on the link provided in the title of each medication to access the third-party site of the resource.

Ketoconazole

Brand Names: Nizoral, Extina, Xolegel, Kuric

Type: Tablets, 200 mg (oral administration)

Indication: No FDA-approved indication

Mitotane

Brand Name: Lysodren

Type: Tablet, 500 mg (oral administration)

Indication: Treatment of inoperable adrenal cortical carcinoma of both functional and nonfunctional types

Aminoglutethimide

Brand Name: Cytadren

Type: Tablet, 250 mg (oral administration)

Indication: Suppression of adrenal function in selected patients

Metyrapone

Brand Name: Metopirone

Type: Capsule, 250 mg (oral administration)

Indication: Diagnostic drug for testing hypothalamic-pituitary ACTH function

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
© 2025 MJH Life Sciences

All rights reserved.